Literature DB >> 24652973

Draft Genome Sequence of Israeli Outbreak-Associated Vibrio vulnificus Biotype 3 Clinical Isolate BAA87.

Kelsey E Phillips1, Matthew J Schipma, Karla J F Satchell.   

Abstract

Vibrio vulnificus is a seafood-associated pathogen that causes severe wound and intestinal infections. Biotype 3 of V. vulnificus emerged in 1996 as the cause of an Israeli outbreak associated with the handling of infected tilapia. Here, we describe the whole-genome sequence of the ATCC biotype 3 clinical isolate BAA87 (CDC9530-96).

Entities:  

Year:  2014        PMID: 24652973      PMCID: PMC3961720          DOI: 10.1128/genomeA.00032-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Vibrio vulnificus is a Gram-negative bacterial pathogen found in coastal waters and causes gastroenteritis, primary septicemia, and necrotizing fasciitis in humans. The mortality rates for primary sepsis and wound infection are 50% and 15%, respectively, and the annual incidence of infections is increasing with climate change (1–4). The presence of V. vulnificus in oysters and other shellfish within coastal waters poses a large risk to the humans that handle them, and thus the characterization of this pathogen is critical (5). Strains have previously been classified as either biotype 1 (BT1), which is most commonly associated with clinical infections, or biotype 2 (BT2), which causes infections in eels (6–8). However, between 1996 and 1999, an outbreak caused by V. vulnificus of the biotype 3 (BT3) lineage resulted in wound infections due to the handling of infected tilapia (9). Biotype 3 strains now cause wound infections in handlers of fish from the seas of Israel, with a death rate of 10% and survivors experiencing severe morbidity (10). Due to the sudden emergence and clonality of the Israeli BT3 strains (11), it is hypothesized that this is a newly emerged pathogen, and thus further investigation into the BT3 genome is pertinent in order to determine how the genomic content may affect disease progression. In this paper, we describe the draft genome sequence of the clinical isolate V. vulnificus strain ATCC BAA87 (CDC9530-96), which was isolated from a patient wound during the original Israel epidemic in 1996. A total of 53.5 ng/μl of genomic DNA was extracted using the Qiagen DNeasy genomic DNA prep for Gram-negative bacterial cultures, according to the manufacturer’s instructions. The DNA library was generated by the Northwestern University Genomics Core Facility and subsequently sequenced using the Life Technologies Ion Torrent PGM technology, specifically the 318 Chip paired with a 400-bp library. The genome was assembled using Newbler (GS de novo Assembler version 2.7) from 454 Life Sciences, with 1,022,286 total reads generating 218 contigs from 400-bp trimmed reads. The genome was aligned to V. vulnificus BT3 environmental isolate VVyb1(BT3) (12) using Torrent Mapper (TMAP) version 3.4.1. BAA87 has a 97.5% alignment to the reference genome, with an average coverage of 52×. The assembled genome was annotated using the Rapid Annotations using Subsystems Technology (RAST), a SEED-based prokaryotic genome annotation service (13).

Nucleotide sequence accession numbers.

The whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. JDSE00000000. The version described in this paper is version JSDE00000000.1.
  12 in total

1.  Climate change and the emergence of Vibrio vulnificus disease in Israel.

Authors:  S Paz; N Bisharat; E Paz; O Kidar; D Cohen
Journal:  Environ Res       Date:  2006-09-01       Impact factor: 6.498

Review 2.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

3.  Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group.

Authors:  N Bisharat; V Agmon; R Finkelstein; R Raz; G Ben-Dror; L Lerner; S Soboh; R Colodner; D N Cameron; D L Wykstra; D L Swerdlow; J J Farmer
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

4.  Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans.

Authors:  C Amaro; E G Biosca
Journal:  Appl Environ Microbiol       Date:  1996-04       Impact factor: 4.792

5.  Vibrio vulnificus biogroup 2: new biogroup pathogenic for eels.

Authors:  D L Tison; M Nishibuchi; J D Greenwood; R J Seidler
Journal:  Appl Environ Microbiol       Date:  1982-09       Impact factor: 4.792

Review 6.  The interactions of Vibrio vulnificus and the oyster Crassostrea virginica.

Authors:  Brett Froelich; James D Oliver
Journal:  Microb Ecol       Date:  2013-01-03       Impact factor: 4.552

7.  Environmental occurrence and clinical impact of Vibrio vulnificus and Vibrio parahaemolyticus: a European perspective.

Authors:  Craig Baker-Austin; Louise Stockley; Rachel Rangdale; Jaime Martinez-Urtaza
Journal:  Environ Microbiol Rep       Date:  2010-01-06       Impact factor: 3.541

8.  Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems.

Authors:  Anna Newton; Magdalena Kendall; Duc J Vugia; Olga L Henao; Barbara E Mahon
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

9.  Hybrid Vibrio vulnificus.

Authors:  Naiel Bisharat; Daniel I Cohen; Rosalind M Harding; Daniel Falush; Derrick W Crook; Tim Peto; Martin C Maiden
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  4 in total

1.  MARTX effector cross kingdom activation by Golgi-associated ADP-ribosylation factors.

Authors:  Byoung Sik Kim; Karla J F Satchell
Journal:  Cell Microbiol       Date:  2016-02-19       Impact factor: 4.115

Review 2.  Multifunctional-autoprocessing repeats-in-toxin (MARTX) Toxins of Vibrios.

Authors:  Karla J F Satchell
Journal:  Microbiol Spectr       Date:  2015-06

3.  Vibrio vulnificus biotype 3 multifunctional autoprocessing RTX toxin is an adenylate cyclase toxin essential for virulence in mice.

Authors:  Kevin J Ziolo; Hee-Gon Jeong; Jayme S Kwak; Shuangni Yang; Robert M Lavker; Karla J F Satchell
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.609

4.  Comparative genomic analysis of clinical and environmental Vibrio vulnificus isolates revealed biotype 3 evolutionary relationships.

Authors:  Yael Koton; Michal Gordon; Vered Chalifa-Caspi; Naiel Bisharat
Journal:  Front Microbiol       Date:  2015-01-15       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.